Track topics on Twitter Track topics that are important to you
Alliqua BioMedical (Nasdaq:ALQA) and Adynxx a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua’s outstanding common stock on a fully-diluted basis. As quoted in the press release: The proposed merger will create a public clinical-stage … Continued
The post Alliqua BioMedical and Adynxx Announce Merger Agreement appeared first on Investing News Network.
Original Article: Alliqua BioMedical and Adynxx Announce Merger AgreementNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...